Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues
İbrahim Halil Şahin, Kristen K. Ciombor, Luis A. Díaz, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 242-253
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Mechanisms of metastatic colorectal cancer
Adrià Cañellas‐Socias, Elena Sancho, Eduard Batlle
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 609-625
Closed Access | Times Cited: 35
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
Javier Ros, Francesca Balconi, Iosune Baraibar, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 29
Update on Emerging Therapies for Advanced Colorectal Cancer
Olatunji B. Alese, Christina Wu, William J. Chapin, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 27
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
Scott Kopetz, Danielle Murphy, Jie Pu, et al.
Nature Medicine (2024)
Open Access | Times Cited: 12
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review
Deniz Can Güven, Gözde Kavgacı, Enes Erul, et al.
The Oncologist (2024) Vol. 29, Iss. 5, pp. e580-e600
Open Access | Times Cited: 9
Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling
Alison A. Chomiak, Rochelle L. Tiedemann, Yanqing Liu, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 9
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
Javier Ros, Iosune Baraibar, Nadia Saoudi, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4245-4245
Open Access | Times Cited: 22
Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions
Samantha Sharma, Naresh Singh, Anita Turk, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1815-1835
Open Access | Times Cited: 8
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer—the randomised METIMMOX trial
Anne Hansen Ree, Jūratė Šaltytė Benth, Hanne Hamre, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 12, pp. 1921-1928
Open Access | Times Cited: 7
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer
Yi Zhou, Huali Li, Yaxin Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216836-216836
Open Access | Times Cited: 6
Colorectal Cancer with BRAF V600E Mutation: Trends in Immune Checkpoint Inhibitor Treatment
Mengling Liu, Qing Liu, Keshu Hu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104497-104497
Closed Access | Times Cited: 5
Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers
Yiping Liu, Hanlin Chen, Hua Bao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Interferon Gamma Induces Higher Neutrophil Extracellular Traps Leading to Tumor-Killing Activity in Microsatellite Stable Colorectal Cancer
Hao‐Wei Teng, Tean-Ya Wang, Chun‐Chi Lin, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 7, pp. 1043-1056
Closed Access | Times Cited: 4
61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 9, pp. 1427-1434
Open Access | Times Cited: 4
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
Unveiling TNFAIP8L2-related Immune Evasion Mechanisms in Colorectal Cancer
David H. Mauki, Ping Li, Shuyao Lang, et al.
Deleted Journal (2025), pp. 100041-100041
Open Access
The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer
Kai Ding, Pei Mou, Zhe Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy
Elias Bou Farhat, Elio Adib, Melissa Daou, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 6-7
Closed Access | Times Cited: 8
The Importance of HHLA2 in Solid Tumors—A Review of the Literature
Agnieszka Kula, Dominika Koszewska, Anna Kot, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 794-794
Open Access | Times Cited: 3
The Influence of the Microbiome on Metastatic Colorectal Cancer
Samuel Cass, Michael G. White
Clinics in Colon and Rectal Surgery (2023) Vol. 36, Iss. 02, pp. 112-119
Closed Access | Times Cited: 7
Identification of ferroptosis-associated tumor antigens as the potential targets to prevent head and neck squamous cell carcinoma
Qiming Zhai, Zhiwei Wang, Han Tang, et al.
Genes & Diseases (2024) Vol. 11, Iss. 6, pp. 101212-101212
Open Access | Times Cited: 2
Prognostic and predictive role of immune microenvironment in colorectal cancer
Olesya Kuznetsova, М. Yu. Fedyanin, Л Э Завалишина, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 3, pp. 643-652
Open Access | Times Cited: 2
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications
Anna Amela Valsecchi, Giorgia Ferrari, Chiara Paratore, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104328-104328
Closed Access | Times Cited: 2
Molecular Landscape and Therapeutic Strategies against Colorectal Cancer
Aakash Patel, Pat Gulhati
Cancers (2024) Vol. 16, Iss. 8, pp. 1551-1551
Open Access | Times Cited: 2
It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
Shiya Yao, Yuejun Han, Mengxiang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top